New York ranked third nationally for access to abortion pills via telehealth as a record 25% of American abortions now occur through telemedicine following the overturning of Roe v. Wade, according to a new study released today by Carafem.
The study analyzed six metrics across legality, accessibility and demand using data from KFF, UCLA, Guttmacher Institute, Plan C and Carafem’s internal records, revealing how patients in states with abortion bans increasingly seek pills from out-of-state providers navigating a complex and rapidly evolving legal landscape.

New York tied for first place nationally with the strongest legal protections, including seven shield law provisions protecting providers and patients from out-of-state prosecution, while also leading the nation with 33 in-state abortion pill providers—more than any other state.
The state recorded 2,208 visits per 100,000 residents to Carafem’s website between 2022 and 2025, ranking 10th nationally for demand, though only 7% of New York abortions were conducted through online-only providers, ranking 25th among states.
The 10 states with the most access to abortion pills online are: Maine, Colorado, New York, Maryland, California, New Mexico, Massachusetts, Virginia, Vermont and Illinois. These states combine strong legal frameworks with high provider availability.
The study arrives as legal access to abortion pills varies dramatically across states and uncertain legal protections and enforcement that continues to shift in real time. Abortion telehealth services are emerging as a critical option for patients in states with restrictions and bans.




